> ## Content Index
> Fetch the complete content index at: https://www.sanarelab.science/llms.txt
> Use this file to discover other available public pages before exploring further.

# How Old Drugs Could Steer a Fiery Cell-Death Pathway in Cancer — New Review Maps the Options
- URL: https://www.sanarelab.science/gasdermin-pyroptosis-disulfiram-cancer-review-2026/
- Published: 2026-10-03T08:15:19.000Z
- Updated: 2026-10-12T12:31:12.000Z
- Description: A new review explains pyroptosis — an inflammatory cell death executed by gasdermin proteins — and weighs repurposed drugs like disulfiram as ways to control it in cancer.
- Author: Sanare Lab
- Tags: #short-read, News, Research, Repurposed Drugs

Key Takeaway

When a cell dies by pyroptosis — a fiery form of self-destruction that alerts the immune system — proteins called gasdermins punch the fatal holes in its membrane. A new review maps this family and the drugs that can control it, including disulfiram, an old alcohol-aversion pill. In cancer the pathway cuts both ways; the paper maps existing research, not new experiments.

Pyroptosis ends with the cell membrane rupturing and spilling pro-inflammatory cytokines — signaling molecules like IL-1β and IL-18 that rally immune cells to the scene. The review details how gasdermins are activated, form pores and cause rupture, and how this death mode crosstalks with others (apoptosis, necroptosis, PANoptosis — other cell-suicide routes).

Outside cell death, gasdermins act in mucus secretion, bone resorption and mitochondrial metabolism; in disease they are double-edged: defending against infections, driving chronic inflammation in autoimmune disorders, and playing context-dependent roles in cancer and immunity. The authors evaluate small-molecule inhibitors — disulfiram (DSF), necrosulfonamide and dimethyl fumarate — plus material-based delivery systems.

Honest framing: this review synthesizes published studies — no new patients, mice or numbers of its own; its value is the map. For related reading, see [a new trial testing disulfiram with copper in thoracic cancer](https://www.sanarelab.science/minter-trial-disulfiram-copper-radiotherapy-thoracic-cancer-2026/) and [pyroptosis triggered by another repurposed drug, fenbendazole](https://www.sanarelab.science/fenbendazole-breast-cancer-pyroptosis-2025/); for dosing questions, our [dosing calculator](https://www.sanarelab.science/protocol-dosing-workspace/).

## In plain words

**What happened:** Scientists published a big review — a summary of existing research — on gasdermins, proteins that execute a fiery, immune-alerting cell death called pyroptosis, and on drugs that control them.

**Why it matters:** This death pathway is like a burglar alarm: useful when it attracts immune cells to a tumor, harmful when it fuels chronic inflammation. Old drugs — including disulfiram, the alcohol-aversion pill — can turn it up or down, hence the need for a map.

**How strong is the evidence:** A review, not an experiment: it organizes what hundreds of labs already found. Reliable as a map, but it reports no new patients or results itself.

**What it means for you:** Nothing changes today — this is background science, not a new therapy. Do not take disulfiram or any drug outside medical care; ask your oncology team about trials if interested.

## References

1. Xu W, Liu S, Yu Z, et al. The gasdermin family: from pyroptosis mechanisms to therapeutic targets (a review — a synthesis of existing research). *Signal Transduction and Targeted Therapy*. 2026 Oct 2\. [doi:10.1038/s41392-026-02867-2](https://doi.org/10.1038/s41392-026-02867-2?ref=sanarelab.science). [PMID: 42823398](https://pubmed.ncbi.nlm.nih.gov/42823398/?ref=sanarelab.science).

## Medical Disclaimer

This article is for informational purposes only and is not medical advice. The paper is a review of existing research and reports no new clinical results. Never start, stop or change any medication without consulting a licensed healthcare provider.